Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gyroscope Therapeutics
Biotech
J&J's medtech chief out the door—Chutes & Ladders
J&J’s medtech head departs after almost 30 years. Ex-Gyroscope CEO leads new biotech. BrainStorm ditches CMO after withdrawing FDA application.
Max Bayer
,
Gabrielle Masson
Oct 27, 2023 9:30am
Aiolos Bio launches with $245M to advance severe asthma med
Oct 24, 2023 7:00am
Novartis cuts eye disease drug on weak data amid restructuring
Sep 11, 2023 9:05am
Novartis inks $800M buyout of eye disease gene therapy biotech
Dec 22, 2021 5:30am
Gyroscope spins the wheel again as it taps Sanofi for $60M
Nov 8, 2021 9:10am
Gyroscope finds IPO market unnavigable
May 7, 2021 10:42am
